{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:34:24Z","timestamp":1771619664969,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.067","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T11:31:44Z","timestamp":1510140704000},"page":"6984-6989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effectiveness of shingles vaccine among Albertans aged 50\u202fyears or older: A retrospective cohort study"],"prefix":"10.1016","volume":"35","author":[{"given":"Bruce M.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas C.","family":"Dover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley A.","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3391-578X","authenticated-orcid":false,"given":"Lawrence W.","family":"Svenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret L.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2017.10.067_b0005","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/652404","article-title":"Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap","volume":"201","author":"Weinberg","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.067_b0010","unstructured":"Drug Product Database. Ottawa: Health Canada; 2015 [accessed 2016 Aug. 05]; Available from: http:\/\/webprod5.hc-sc.gc.ca\/dpd-bdpp\/info.do?code=80146&lang=eng http:\/\/webprod5.hc-sc.gc.ca\/dpd-bdpp\/info.do?code=86093&lang=eng"},{"key":"10.1016\/j.vaccine.2017.10.067_b0015","unstructured":"Canadian Immunization Guide [Internet]. Ottawa: Health Canada; 2014 [accessed 2016 Aug. 05]; [Herpes Zoster (Shingles) Vaccine]. Available from: http:\/\/www.phac-aspc.gc.ca\/publicat\/cig-gci\/p04-herp-zona-eng.php#epi"},{"key":"10.1016\/j.vaccine.2017.10.067_b0020","unstructured":"Update on the use of herpes zoster vaccine [Internet]. Ottawa: National Advisory Committee on Immunization; 2014 [accessed 2016 Aug. 05]; Available from: http:\/\/www.phac-aspc.gc.ca\/naci-ccni\/hzv-vcz-eng.php"},{"key":"10.1016\/j.vaccine.2017.10.067_b0025","unstructured":"Zoster (Shingles) ACIP Vaccine Recommendations [Internet]. Atlanta: Centers for Disease Control; 2014 [accessed 2016 Aug. 05]; [Vaccine Recommendations of the ACIP]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/vacc-specific\/shingles.html"},{"key":"10.1016\/j.vaccine.2017.10.067_b0030","unstructured":"Alberta health care insurance plan statistical supplement [Internet]. Edmonton: Government of Alberta; 2014 [accessed 2016 Aug. 11]. Available from: www.health. alberta.ca\/documents\/AHCIP-Stats-Supplement-14.pdf."},{"issue":"212","key":"10.1016\/j.vaccine.2017.10.067_b0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/infdis\/jiv164","article-title":"Zoster vaccination increases the breadth of CD4+ T cells responsive to varicella zoster virus","volume":"17","author":"Laing","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.067_b0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/infdis\/jis334","article-title":"Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population","volume":"206","author":"Tseng","year":"2012","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.067_b0045","first-page":"1055","article-title":"Field evaluation of vaccine efficacy","volume":"63","author":"Orenstein","year":"1995","journal-title":"Bulletin World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.067_b0050","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cid\/ciw854","article-title":"Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccine in the medicare population ages 65 years and older","volume":"64","author":"Izurieta","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.067_b0055","doi-asserted-by":"crossref","unstructured":"Langan S, Smeeth L, Margolis D, Thomas S. Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study. PLoS Medicine. 2013 Apr 9; 10(4).","DOI":"10.1371\/journal.pmed.1001420"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.067_b0060","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.10.067_b0065","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of herpes zoster vaccine in adults aged \u226560 years","volume":"213","author":"Tseng","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.067_b0070","unstructured":"Shingles Surveillance [Internet]. Atlanta, GA: Centers for Disease Control; 2016 [accessed 2017 Feb. 01]; [Trends]. Available from: https:\/\/www.cdc.gov\/shingles\/surveillance.html"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.067_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S095026880400281X","article-title":"Incidence of herpes zoster, 1997\u20132002","volume":"133","author":"Mullooly","year":"2005","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2017.10.067_b0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"10.1016\/j.vaccine.2017.10.067_b0085","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"The shingles prevention study group. a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"OxmanLevin","year":"2005","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2017.10.067_b0090","doi-asserted-by":"crossref","unstructured":"Oxman M, Levin M, The Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia. J Infect Disease 2008; 197(Suppl 2): S228\u201336.","DOI":"10.1086\/522159"},{"issue":"7","key":"10.1016\/j.vaccine.2017.10.067_b0095","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Effectiveness, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.067_b0100","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.067_b0105","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4065\/mcp.2011.0305","article-title":"Herpes zoster and postherpetic neuralgia surveillance using structured electronic data","volume":"86","author":"Klompas","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"47","key":"10.1016\/j.vaccine.2017.10.067_b0110","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/j.vaccine.2013.09.018","article-title":"Shingles in Alberta: Before and after publicly funded varicella vaccination","volume":"32","author":"Russell","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.067_b0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/kwr206","article-title":"Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?","volume":"174","author":"Yawn","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"22","key":"10.1016\/j.vaccine.2017.10.067_b0120","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"For the ZOE-50 study group efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T01:51:00Z","timestamp":1535248260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17314755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":24,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17314755"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of shingles vaccine among Albertans aged 50\u202fyears or older: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}